These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9711254)

  • 1. Structure-activity relationships of 1 beta-methyl-carbapenems to antimicrobial activity: effect of C-6 substituent.
    Sunagawa M; Matsumura H; Sasaki A; Yamaga H; Kitamura Y; Sumita Y; Nouda H
    J Antibiot (Tokyo); 1997 Jul; 50(7):621-7. PubMed ID: 9711254
    [No Abstract]   [Full Text] [Related]  

  • 2. 1 beta-Methyl-2(5-substituted pyrrolidin-3-ylthio)carbapenems. 1. Synthesis and antibacterial activity of BO-2502A and its related compounds.
    Ohtake N; Yamada K; Mano E; Okamoto O; Ushijima R; Nakagawa S
    J Antibiot (Tokyo); 1997 Jul; 50(7):567-85. PubMed ID: 9711249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antibacterial activity of novel 4-pyrrolidinylthio carbapenems--I. 2-Alkoxymethyl derivatives.
    Azami H; Tsutsumi H; Matsuda K; Barrett D; Hattori K; Nakajima T; Kuroda S; Kamimura T; Murata M
    Bioorg Med Chem; 1997 Nov; 5(11):2069-87. PubMed ID: 9416424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial activity of some (C2)-heterobicyclyl carbapenem derivatives.
    Burton G; Coulton S; Harrington FP; Hinks JD; Holland RK; Hunt E; Pearson MJ
    J Antibiot (Tokyo); 1998 Jun; 51(6):599-601. PubMed ID: 9711227
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the in vitro activity of meropenem and doripenem against Pseudomonas aeruginosa and multidrug-resistant Enterobacteriaceae.
    Van Gasse N; Vermeiren S; Jeurissen A
    Acta Clin Belg; 2010; 65(6):451. PubMed ID: 21268965
    [No Abstract]   [Full Text] [Related]  

  • 6. In-vitro interactions of DX-8739, a new carbapenem, meropenem and imipenem with amikacin against multiresistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Grecka P; Giamarellou H
    J Antimicrob Chemother; 1996 Aug; 38(2):287-91. PubMed ID: 8877544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallo-β-lactamase inhibitory activity of 3-alkyloxy and 3-amino phthalic acid derivatives and their combination effect with carbapenem.
    Hiraiwa Y; Morinaka A; Fukushima T; Kudo T
    Bioorg Med Chem; 2013 Sep; 21(18):5841-50. PubMed ID: 23920484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivities to four carbapenems of bacteria isolated from patients with refractory complicated urinary tract infections and the detection of carbapenemase-producing Pseudomonas aeruginosa.
    Matsumoto T; Kumazawa J; Nagayama A
    J Antimicrob Chemother; 1996 Aug; 38(2):322-4. PubMed ID: 8877553
    [No Abstract]   [Full Text] [Related]  

  • 9. Bactericidal activity of meropenem against Pseudomonas aeruginosa.
    Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():169-74. PubMed ID: 2509414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative antibacterial activity of carbapenems against P. aeruginosa (1)].
    Hikida M; Terashima S; Sato Y; Okamoato R; Inoue M
    Jpn J Antibiot; 2001 Nov; 54(11):571-9. PubMed ID: 11828603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of carbapenems to the antagonism of the antipseudomonal activity of other beta-lactam agents and to the beta-lactamase inducibility in Pseudomonas aeruginosa: effects of 1beta-methyl group and C-2 side chain.
    Kanazawa K; Nouda H; Sumita Y; Sunagawa M
    J Antibiot (Tokyo); 1999 Feb; 52(2):142-9. PubMed ID: 10344568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of meropenem, imipenem, cefepime and ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Christenson JC; Korgenski EK; Daly JA
    J Antimicrob Chemother; 2000 Jun; 45(6):899-901. PubMed ID: 10837448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IMP-51, a novel IMP-type metallo-β-lactamase with increased doripenem- and meropenem-hydrolyzing activities, in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.
    Tada T; Nhung PH; Miyoshi-Akiyama T; Shimada K; Phuong DM; Anh NQ; Ohmagari N; Kirikae T
    Antimicrob Agents Chemother; 2015 Nov; 59(11):7090-3. PubMed ID: 26282421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a beta-lactamase inhibitor, sulbactam, on the activity of carbapenems against Pseudomonas aeruginosa.
    Hazumi N; Kato Y; Hashizume T; Matsuda K
    J Antibiot (Tokyo); 1995 Nov; 48(11):1364-7. PubMed ID: 8557585
    [No Abstract]   [Full Text] [Related]  

  • 15. [A novel carbapenem active against imipenem resistant strains of Pseudomonas aeruginosa].
    Sazykin YuO
    Antibiot Khimioter; 1997; 42(8):42. PubMed ID: 9412413
    [No Abstract]   [Full Text] [Related]  

  • 16. Carbapenems in the USA: focus on doripenem.
    Lister PD
    Expert Rev Anti Infect Ther; 2007 Oct; 5(5):793-809. PubMed ID: 17914914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of carbapenem compounds to anti-Haemophilus influenzae activity and affinity for penicillin-binding proteins. Effect of 1 beta-methyl group and C-2 side chain.
    Kanazawa K; Nouda H; Sunagawa M
    J Antibiot (Tokyo); 1997 Feb; 50(2):162-8. PubMed ID: 9099227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postantibiotic effects of three carbapenems on Pseudomonas aeruginosa in the presence of lysine.
    Boswell FJ; Andrews JM; Gill MJ; Wise R
    J Antimicrob Chemother; 1995 Jan; 35(1):232-3. PubMed ID: 7768777
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of basic amino acids on susceptibility to carbapenems in clinical Pseudomonas aeruginosa isolates.
    Muramatsu H; Horii T; Morita M; Hashimoto H; Kanno T; Maekawa M
    Int J Med Microbiol; 2003 Jun; 293(2-3):191-7. PubMed ID: 12868655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro sensitivity of Acinetobacter baumannii and Pseudomonas aeruginosa to carbapenems among intensive care unit patients.
    Guzek A; Korzeniewski K; Nitsch-Osuch A; Rybicki Z; Prokop E
    Adv Exp Med Biol; 2013; 788():109-16. PubMed ID: 23835967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.